Merck Stock Up as Winrevair Meets Goal in Advanced PAH Study
| LCCCX Fund | USD 32.65 0.01 0.03% |
Slightly above 55% of Columbia Contrarian's investor base is interested to short. The analysis of overall sentiment of trading Columbia Trarian Core mutual fund suggests that many investors are impartial at this time. Columbia Contrarian's investing sentiment can be driven by a variety of factors including economic data, Columbia Contrarian's earnings reports, geopolitical events, and overall market trends.
COLUMBIA |
MRKs study of PAH drug Winrevair in a more advanced form of the disease shows overwhelming efficacy.
Read at zacks.com
 |
Columbia Contrarian Fundamental Analysis
We analyze Columbia Contrarian's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Columbia Contrarian using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Columbia Contrarian based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Columbia Trarian is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Columbia Trarian Core Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Columbia Contrarian mutual fund to make a market-neutral strategy. Peer analysis of Columbia Contrarian could also be used in its relative valuation, which is a method of valuing Columbia Contrarian by comparing valuation metrics with similar companies.
Peers
Columbia Contrarian Related Equities
| CTHCX | Columbia Global | 0.48 | ||||
| LCCAX | Columbia Contrarian | 0.03 | ||||
| CBLCX | Columbia Balanced | 0.02 | ||||
| LBSCX | Columbia Dividend | 0.40 |
Other Information on Investing in COLUMBIA Mutual Fund
Columbia Contrarian financial ratios help investors to determine whether COLUMBIA Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in COLUMBIA with respect to the benefits of owning Columbia Contrarian security.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |